Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Active Biotech AB ( (SE:ACTI) ) has shared an update.
Active Biotech AB has announced an Extraordinary General Meeting to discuss significant changes, including amendments to the Articles of Association and a new share issue. The proposed changes aim to increase the company’s share capital and authorize the Board to issue new shares, potentially impacting the company’s financial structure and attracting new investors.
More about Active Biotech AB
Active Biotech AB is a biotechnology company based in Lund, Sweden, focusing on the development of pharmaceuticals for the treatment of autoimmune diseases and cancer.
YTD Price Performance: 44.44%
Average Trading Volume: 4,892,505
Technical Sentiment Signal: Sell
Current Market Cap: SEK192.6M
See more data about ACTI stock on TipRanks’ Stock Analysis page.